53
Views
13
CrossRef citations to date
0
Altmetric
Reviews

Advances in the treatment of postpartum hemorrhage

, , &
Pages 525-537 | Published online: 10 Jan 2014

References

  • Khan KS, Wojdyla D, Say L, Gulmezoglu AM, Van Look PF. WHO analysis of causes of maternal death: a systematic review. Lancet 367(9516), 1066–1074 (2006).
  • Lozano R, Wang H, Foreman K et al. Progress towards Millennium Development Goals 4 and 5 on maternal and child mortality: an updated systematic analysis. Lancet 378(9797), 1139–1165 (2011).
  • Abouzahr C. Global burden of maternal death and disability. Br. Med. Bulletin 67, 1–11 (2003).
  • Clark SL, Belfort MA, Dildy GA, Herbst MA, Meyers JA, Hankins GD. Maternal death in the 21st century: causes, prevention, and relationship to cesarean delivery. Am. J. Obstet. Gynecol.199(1), 36.e1–e5, discussion 91–92.e7–e11 (2008).
  • Guillermo Carroli CC, Edgardo Abalos, A. Metin Gulmezoglu. Epidemiology of postpartum haemorrhage: a systematic review. Best Pract. Res. Clin. Obstet. Gynaecol. 22(6), 999–1012 (2008).
  • World Health Organization. WHO recommendations for the prevention and treatment of postpartum hemorrhage. (2012).
  • Andersen HF, Hopkins MP. Postpartum Hemorrhage Postpartum Hemorrhage (2012).
  • Schorn MN. Measurement of blood loss: review of the literature. J. MidwiferyWomens Health 55(1), 20–27 (2010).
  • Chandraharan E, Arulkumaran S. Surgical aspects of postpartum haemorrhage. Best Pract Res Clin Obstet Gynaecol. 22(6), 1089–1102 (2008).
  • Lu MC, Fridman M, Korst LM et al. Variations in the incidence of postpartum hemorrhage across hospitals in California. Matern. Child Health J. 9(3), 297–306 (2005).
  • Bateman BT, Berman MF, Riley LE, Leffert LR. The epidemiology of postpartum hemorrhage in a large, nationwide sample of deliveries. Anesth. Analg. 110(5), 1368–1373 (2010).
  • Calvert C, Thomas SL, Ronsmans C, Wagner KS, Adler AJ, Filippi V. Identifying regional variation in the prevalence of postpartum haemorrhage: a systematic review and meta-analysis. PLoS ONE 7(7)(2012).
  • Knight M, Callaghan WM, Berg C et al. Trends in postpartum hemorrhage in high resource countries: a review and recommendations from the International Postpartum Hemorrhage Collaborative Group. BMC Pregnancy Childbirth 9, 55 (2009).
  • Joseph KS, Rouleau J, Kramer MS, Young DC, Liston RM, Baskett TF. Investigation of an increase in postpartum haemorrhage in Canada. BJOG 114(6), 751–759 (2007).
  • Wu S, Kocherginsky M, Hibbard JU. Abnormal placentation: twenty-year analysis. Am J. Obstet. Gynecol.192(5), 1458–1461 (2005).
  • Oyelese Y, Ananth CV. Postpartum hemorrhage: epidemiology, risk factors, and causes. Clin. Obstet. Gynecol. 53(1), 147–156 (2010).
  • Bauer ST, Bonanno C. Abnormal placentation. Sem. Perinatol. 33(2), 88–96 (2009).
  • Benedetto C, Marozio L, Tavella AM, Salton L, Grivon S, Di Giampaolo F. Coagulation disorders in pregnancy: acquired and inherited thrombophilias. Ann. N.Y. Acad. Sci. 1205, 106–117 (2010).
  • Carle C, Alexander P, Columb M, Johal J. Design and internal validation of an obstetric early warning score: secondary analysis of the Intensive Care National Audit and Research Centre Case Mix Programme database. Anaesthesia 68(4), 354–367 (2013).
  • Coker A, Oliver R. Definitions and classifications. In: A Textbook of Postpartum Hemorrhage,(1st Editon). Arulkumaran S, Karoshi M, Keith LG, Lalonde AB, B-Lynch C (Eds). Jaypee Brothers Publishers, Dumfriesshire, UK (2006).
  • Singh S, Mcglennan A, England A, Simons R. A validation study of the CEMACH recommended modified early obstetric warning system (MEOWS). Anaesthesia 67(1), 12–18 (2012).
  • Guidelines and Audit Committee of the Royal College of Obstetricians and Gynaecologists. Prevention and Management of Postpartum Haemorrhage. RCOG Green-top Guideline No. 52. (April 2011).
  • Pacagnella RC, Souza JP, Durocher J et al. A systematic review of the relationship between blood loss and clinical signs. PLoS ONE 8(3), e57594 (2013).
  • Patel A, Goudar SS, Geller SE et al. Drape estimation vs. visual assessment for estimating postpartum hemorrhage. Int. J. Gynaecol. Obstet. 93(3), 220–224 (2006).
  • Low-cost Mobile Platform for Real-Time Monitoring of Blood Loss. 2013 (May 10) (2011).
  • National Institute for Health and Clinical Excellence CG55. Intrapartum care: Care of healthy women and their babies during childbirth (2007).
  • Lalonde A. Prevention and treatment of postpartum hemorrhage in low-resource settings. Int. J. Gynaecol. Obstet. 117(2), 108–118 (2012).
  • Su LL, Chong YS, Samuel M. Carbetocin for preventing postpartum haemorrhage. Cochrane Database Syst. Rev. (Online) 2, CD005457 (2012).
  • Del Angel-Garcia G, Garcia-Contreras F, Constantino-Casas P et al. Economic evaluation of carbetocine for the prevention of uterine atony in patients with risk factors in Mexico. Value Health 9(6), A254–A254 (2006).
  • Gizzo S, Patrelli TS, Gangi SD et al. Which uterotonic is better to prevent the postpartum hemorrhage? latest news in terms of clinical efficacy, side effects, and contraindications: a systematic review. Reprod. Sci. 20(9), 1011–1019(2013).
  • Novikova N, Hofmeyr GJ. Tranexamic acid for preventing postpartum haemorrhage. Cochrane Database syst. Rev. (Online) (7), CD007872 (2010).
  • Ducloy-Bouthors AS, Jude B, Duhamel A et al. High-dose tranexamic acid reduces blood loss in postpartum haemorrhage. Crit. care 15(2), R117 (2011).
  • Xu J, Gao W, Ju Y. Tranexamic acid for the prevention of postpartum hemorrhage after cesarean section: a double-blind randomization trial. Arch. Gynecol. Obstet. 287(3), 463–468 (2013).
  • Shakur H, Elbourne D, Gulmezoglu M et al. The WOMAN Trial (World Maternal Antifibrinolytic Trial): tranexamic acid for the treatment of postpartum haemorrhage: an international randomised, double blind placebo controlled trial. Trials 11, 40 (2010).
  • Duncan A, Wideking CV. Bleeding from the lower genital tract. In: A Textbook of Postpartum Hemorrhage (2nd Edition). Arulumaran S, Karoshi M, Keith LG, Lalonde AB, B-Lynch C (Eds). Jaypee Brothers Publishers, New Delhi, India (2012).
  • Nardin JM, Weeks A, Carroli G. Umbilical vein injection for management of retained placenta. Cochrane Database Syst. Rev. (Online) (5), CD001337 (2011).
  • Committee on Obstetric Practice. Committee opinion no. 529: placenta accreta. Obstet. Gynecol. 120(1), 207–211 (2012).
  • Garmi G, Salim R. Epidemiology, etiology, diagnosis, and management of placenta accreta. Obstet. Gynecol. Int. 2012, 873929 (2012).
  • Robinson BK, Grobman WA. Effectiveness of timing strategies for delivery of individuals with placenta previa and accreta. Obstet. Gynecol. 116(4), 835–842 (2010).
  • Blanc J, Courbiere B, Desbriere R et al. Uterine-sparing surgical management of postpartum hemorrhage: is it always effective? Arch. Gynecol. Obstet. 285(4), 925–930 (2012).
  • Provansal M, Courbiere B, Agostini A, D'ercole C, Boubli L, Bretelle F. Fertility and obstetric outcome after conservative management of placenta accreta. Int. J. Gynaecol. Obstet. 109(2), 147–150 (2010).
  • Portilla D, Hernandez-Giraldo C, Moreno B et al. A local hemostatic agent for the management of postpartum hemorrhage due to placenta previa and placenta accreta: a cross-sectional study. Arch. Gynecol. Obstet. 288(3), 543–549 (2013).
  • Evans D, B-Lynch C. Obstetric Trauma. In. A Comprehensive Textbook of Postpartum Hemorrhage, (2nd Edition). Arulkumaran S, Karoshi M, Keith LG, Lalonde AB, B-Lynch C (Eds). Sapiens Publishing, Duncow, UK (2012).
  • Fofie C, Baffoe P. A Two-Year Review of Uterine Rupture in a Regional Hospital. Ghana Med. J. 44(3), 98–102 (2010).
  • Holmgren CM. Uterine rupture associated with VBAC. Clin. Obstet. Gynecol. 55(4), 978–987 (2012).
  • Hill JB, Ammons A, Chauhan SP. Vaginal birth after cesarean delivery: comparison of ACOG practice bulletin with other national guidelines. Clin. Obstet. Gynecol. 55(4), 969–977 (2012).
  • Hostetler DR, Bosworth MF. Uterine inversion: a life-threatening obstetric emergency. J. Am. Board Fam. Pract. 13(2), 120–123 (2000).
  • Silver RM, Major H. Maternal coagulation disorders and postpartum hemorrhage. Clin. Obstet. Gynecol. 53(1), 252–264 (2010).
  • Onwuemene O, Green D, Keith L. Postpartum hemorrhage management in 2012: predicting the future. Int. J. Gynaecol. Obstet. 119(1), 3–5 (2012).
  • Padmanabhan A, Schwartz J, Spitalnik SL. Transfusion therapy in postpartum hemorrhage. Sem. Perinatol. 33(2), 124–127 (2009).
  • Thorarinsdottir HR, Sigurbjornsson FT, Hreinsson K, Onundarson PT, Gudbjartsson T, Sigurdsson GH. Effects of fibrinogen concentrate administration during severe hemorrhage. Acta anaesthesiol. Scand. 54(9), 1077–1082 (2010).
  • Bell SF, Rayment R, Collins PW, Collis RE. The use of fibrinogen concentrate to correct hypofibrinogenaemia rapidly during obstetric haemorrhage. Int. J. Obstet. Anesth. 19(2), 218–223 (2010).
  • Warmuth M, Mad P, Wild C. Systematic review of the efficacy and safety of fibrinogen concentrate substitution in adults. Acta anaesthesiologica Scand. 56(5), 539–548 (2012).
  • Wikkelsoe AJ, Afshari A, Stensballe J et al. The FIB-PPH trial: fibrinogen concentrate as initial treatment for postpartum haemorrhage: study protocol for a randomised controlled trial. Trials 13, 110 (2012).
  • Tindell K, Garfinkel R, Abu-Haydar E et al. Uterine balloon tamponade for the treatment of postpartum haemorrhage in resource-poor settings: a systematic review. 120(1), 5–14 (2013).
  • Georgiou C. Balloon tamponade in the management of postpartum haemorrhage: a review. BJOG 116(6), 748–757 (2009).
  • Stefanovic V, Gronvall M, Tikkanen M, Tallberg E, Paavonen J. Bakri balloon tamponade for postpartum hemorrhage. Acta Obstet. Gynecol. Scand. 92(9), 1119 (2013).
  • Frenzel D, Condous GS, Papageorghiou AT, Mcwhinney NA. The use of the “tamponade test” to stop massive obstetric haemorrhage in placenta accreta. BJOG 112(5), 676–677 (2005).
  • Yoong W, Ridout A, Memtsa M et al. Application of uterine compression suture in association with intrauterine balloon tamponade (‘uterine sandwich') for postpartum hemorrhage. Acta Obstet. Gynecol. Scand. 91(1), 147–151 (2012).
  • Lemmer R, Albrech M, Bauer G. Use of FloSeal hemostatic matrix in a patient with severe postpartum hemorrhage. J. Obstet. Gynaecol. Res. 38(2), 435–437 (2012).
  • Soltan MH, Sadek RR. Experience managing postpartum hemorrhage at Minia University Maternity Hospital, Egypt: no mortality using external aortic compression. J. Obstet. Gynaecol. Res. 37(11), 1557–1563 (2011).
  • Riley DP, Burgess RW. External abdominal aortic compression: a study of a resuscitation manoeuvre for postpartum haemorrhage. Anaesth. Intensive care 22(5), 571–575 (1994).
  • Miller S, Fathalla MM, Ojengbede OA et al. Obstetric hemorrhage and shock management: using the low technology Non-pneumatic Anti-Shock Garment in Nigerian and Egyptian tertiary care facilities. BMC Pregnancy Childbirth 10, 64 (2010).
  • Miller S, Turan JM, Dau K et al. Use of the non-pneumatic anti-shock garment (NASG) to reduce blood loss and time to recovery from shock for women with obstetric haemorrhage in Egypt. Global Public Health 2(2), 110–124 (2007).
  • Miller S, El Ayadi A. Meta-analysis of 3,651 Women with Severe Obstetric Hemorrhage/Hypovolemic Shock Treated with Non-Pneumatic Anti-Shock Garment. (2012).
  • Royal College of Obstetricians and Gynaecologists, Royal College of Radiologists, British Society of Interventional Radiology. The Role of Emergency and Elective Interventional Radiology in Postpartum Haemorrhage. Good Practice No. 6. (June 2007).
  • Lagrew D, Hull A. Uterine Artery Occlusion and Embolization. Uterine Artery Occlusion and Embolization (2009).
  • Pacheco LD, Saade GR, Gei AF, Hankins GD. Cutting-edge advances in the medical management of obstetrical hemorrhage. Am. J. Obstet. Gynecol. 205(6), 526–532 (2011).
  • Ganguli S, Stecker MS, Pyne D, Baum RA, Fan CM. Uterine artery embolization in the treatment of postpartum uterine hemorrhage. J. Vasc. Interv. Radiol. 22(2), 169–176 (2011).
  • Luo FY, Chen M, Zhang L et al. [A comparison of the effectiveness of five types of hemostatic surgeries for intractable postpartum haemorrhage and the factors of failed hemostasis]. Zhonghua fu chan ke za zhi 47(9), 641–645 (2012).
  • Maassen MS, Lambers MD, Tutein Nolthenius RP, Van Der Valk PH, Elgersma OE. Complications and failure of uterine artery embolisation for intractable postpartum haemorrhage. BJOG 116(1), 55–61 (2009).
  • Acog. Practice Bulletin: Clinical Management Guidelines for Obstetrician-Gynecologists. 76: Postpartum hemorrhage. Obstet. Gynecol. 108(4), 1039–1047 (2006).
  • Walfish M, Neuman A, Wlody D. Maternal haemorrhage. Br. J. Anaesth. 103(Suppl. 1), i47–i56 (2009).
  • Rath W, Hackethal A, Bohlmann MK. Second-line treatment of postpartum haemorrhage (PPH). Arch. Gynecol. Obstet. 286(3), 549–561 (2012).
  • Shahin AY, Farghaly TA, Mohamed SA, Shokry M, Abd-El-Aal DE, Youssef MA. Bilateral uterine artery ligation plus B-Lynch procedure for atonic postpartum hemorrhage with placenta accreta. Int. J. Gynaecol. Obstet. 108(3), 187–190 (2010).
  • Gutierrez MC, Goodnough LT, Druzin M, Butwick AJ. Postpartum hemorrhage treated with a massive transfusion protocol at a tertiary obstetric center: a retrospective study. Int. J. Obstet. Anesth. 21(3), 230–235 (2012).
  • Burtelow M, Riley E, Druzin M, Fontaine M, Viele M, Goodnough LT. How we treat: management of life-threatening primary postpartum hemorrhage with a standardized massive transfusion protocol. Transfusion 47(9), 1564–1572 (2007).
  • Tanaka KA, Szlam F. Treatment of massive bleeding with prothrombin complex concentrate: argument for. J. Thromb. Haemost. 8(12), 2589–2591 (2010).
  • Maegele M, Lefering R, Yucel N et al. Early coagulopathy in multiple injury: an analysis from the German Trauma Registry on 8724 patients. Injury 38(3), 298–304 (2007).
  • Johansson PI, Oliveri RS, Ostrowski SR. Hemostatic resuscitation with plasma and platelets in trauma. J. Emerg Trauma Shock 5(2), 120–125 (2012).
  • James AH, Mclintock C, Lockhart E. Postpartum hemorrhage: when uterotonics and sutures fail. Am. J. Hematol. 87 (Suppl. 1), S16–S22 (2012).
  • Wikkelsoe AJ, Afshari A, Stensballe J et al. The FIB-PPH trial: fibrinogen concentrate as initial treatment for postpartum haemorrhage: study protocol for a randomised controlled trial. Trials 13, 110 (2012).
  • De Lange NM, Lance MD, De Groot R, Beckers EA, Henskens YM, Scheepers HC. Obstetric hemorrhage and coagulation: an update. Thromboelastography, thromboelastometry, and conventional coagulation tests in the diagnosis and prediction of postpartum hemorrhage. Obstetr. Gynecol. Surv. 67(7), 426–435 (2012).
  • Huissoud C, Carrabin N, Audibert F et al. Bedside assessment of fibrinogen level in postpartum haemorrhage by thrombelastometry. BJOG 116(8), 1097–1102 (2009).
  • Gyamfi C, Berkowitz RL. Management of pregnancy in a Jehovah's Witness. Obstet. Gynecol. Clin. North Am. 34(3), 357–365, ix (2007).
  • Santoso JT, Lin DW, Miller DS. Transfusion medicine in obstetrics and gynecology. Obstetr. Gynecol. Surv. 50(6), 470–481 (1995).
  • Obed JY, Geidam AD, Reuben N. Autologous blood donation and transfusion in obstetrics and gynaecology at the University of Maiduguri Teaching Hospital Maiduguri, Nigeria. Niger. J. Clin. Pract. 13(2), 139–143 (2010).
  • Esper SA, Waters JH. Intra-operative cell salvage: a fresh look at the indications and contraindications. Blood Transfusion 9(2), 139–147 (2011).
  • National Institute for Health and Care Excellence. Intraoperative blood cell salvage in obstetrics (IPG 144). Intraoperative blood cell salvage in obstetrics (IPG 144) (2005).
  • Sobieszczyk S, Breborowicz G. The use of recombinant factor VIIa. In: A Comprehensive Textbook of Postpartum Hemorrhage( 2nd Edition). Arulkumaran SS, Karoshi M, Keith LG, Lalonde AB, B-Lynch C (Eds) (2012).
  • WHO. WHO guidelines for the management of postpartum haemorrhage and retained placenta. 48 (2009).
  • Franchini M, Franchi M, Bergamini V et al. The use of recombinant activated FVII in postpartum hemorrhage. Clin. Obstet. Gynecol. 53(1), 219–227 (2010).
  • Royal College of Obstetrician and Gynaecologists. Postpartum Haemorrhage, Prevention and Management (Green-top 52). (2009).
  • Lau P, Ong V, Tan WT, Koh PL, Hartman M. Use of activated recombinant factor vii in severe bleeding - evidence for efficacy and safety in trauma, postpartum hemorrhage, cardiac surgery, and gastrointestinal bleeding. Transfus. Med. Hemother. 39(2), 139–150 (2012).
  • Bingham D, Melsop K, Main E, The California Maternal Quality Care Collaborative. CMQCC obstetric hemorrhage hospital level implementation guide (2010).
  • Dilla AJ, Waters JH, Yazer MH. Clinical validation of risk stratification criteria for peripartum hemorrhage. Obstet. Gynecol. 122(1), 120–126(2013).
  • Merién AER, Van De Ven J, Mol BW, Houterman S, Oei SG. Multidisciplinary Team training in a simulation setting for acute obstetric emergencies: a systematic review. Obstet. Gynecol. 115(5), 1021–1031 (2010).
  • Walker DM, Cohen SR, Estrada F et al. PRONTO training for obstetric and neonatal emergencies in Mexico. Int. J. Gynaecol. Obstet. 116(2), 128–133 (2012).
  • Casper L, Lee R. OB Hemorrhage: Carts, Kits and Trays. OB Hemorrhage: Carts, Kits and Trays (2009).
  • Baskett TF. Surgical management of severe obstetric hemorrhage: experience with an obstetric hemorrhage equipment tray. J. Obstet. Gynaecol. Can. 26(9), 805–808 (2004).
  • Handbook of Transfusion Medicine. Mcclelland D (Ed.). The Stationary Office, London, UK (2007).
  • Belizan M, Meier A, Althabe F et al. Facilitators and barriers to adoption of evidence-based perinatal care in Latin American hospitals: a qualitative study. Health Edu. Res. 22(6), 839–853 (2007).
  • Miller S, Lester F, Hensleigh P. Prevention and treatment of postpartum hemorrhage: new advances for low-resource settings. J. MidwiferyWomens Health 49(4), 283–292 (2004).
  • Brabin BJ, Hakimi M, Pelletier D. An analysis of anemia and pregnancy-related maternal mortality. J. Nutr. 131(2S–2), 604S–614S, discussion 614S–615S (2001).
  • Smith JM, Gubin R, Holston MM, Fullerton J, Prata N. Misoprostol for postpartum hemorrhage prevention at home birth: an integrative review of global implementation experience to date. BMC Pregnancy Childbirth 13, 44 (2013).
  • Gynuity Health Projects. Postpartum hemorrhage: Moving from Research to Reality. 2013(May 1) (2012).
  • Prevention of Postpartum Hemorrhage Initiative Pilot use of oxytocin in a Uniject− device for AMTSL in Mali: evaluation of the safety and feasibility of a new delivery technology. (April 18, 2010) (2008).
  • Althabe F, Mazzoni A, Cafferata ML et al. Using Uniject to increase the use of prophylactic oxytocin for management of the third stage of labor in Latin America. Int. J. Gynaecol. Obstet. 114(2), 184–189 (2011).
  • PATH. Technology Solutions for Global Health: Oxytocin in Uniject. 2010 (March 29) (2009).
  • Stanton CK, Newton S, Mullany LC, Cofie P, Tawiah Agyemang C et al. Effect on postpartum hemorrhage of prophylactic oxytocin (10 IU) by injection by community health officers in Ghana: a community-based, cluster-randomized trial. PLoS Med. 10(10), e1001524 (2013).
  • Monash University Faculty of Pharmacy and Pharmaceutical Sciences. Inhaled Oxytocin Project. Inhaled Oxytocin Project 2013. (June 1) (2013).
  • Ejembi CL, Norick P, Starrs A, Thapa K. New global guidance supports community and lay health workers in postpartum hemorrhage prevention. Int. J. Gynaecol. Obstet. 122(3), 187–189 (2013).
  • Kapungu C, Koch A, Miller S, Geller S. A community-based continuum of care model for the prevention and management of postpartum hemorrhage in low resource settings. In: A Comprehensive Textbook of Postpartum Hemorrhage: An Essential Clinical Reference for Effective Management. Arulkumaran S, Karoshi M, L.G. K, Lalonde A, B-Lynch C (Eds). Sapiens Publishing, London, UK (2012).
  • Lori JR, Amable EE, Mertz SG, Moriarty K. Behavior change following implementation of home-based life-saving skills in Liberia, West Africa. J. MidwiferyWomens Health 57(5), 495–501 (2012).
  • Prata N, Mbaruku G, Campbell M. Using the kanga to measure postpartum blood loss. Int. J. Gynecol. Obstet. 89(1), 49–50 (2005).
  • Prata N, Quaiyum MA, Passano P et al. Training traditional birth attendants to use misoprostol and an absorbent delivery mat in home births. Soc. Sci. Med. (1982) 75(11), 2021–2027 (2012).
  • Mkumba G, Butrick E, Amafumba R et al. Non-Pneumatic Anti-Shock Garment (NASG) Decreases Maternal Deaths in Lusaka, Zambia. 119(Suppl. 3), S424 (2012).
  • Sutherland T, Downing J, Miller S et al. Use of the non-pneumatic anti-shock garment (NASG) for life-threatening obstetric hemorrhage: a cost-effectiveness analysis in Egypt and Nigeria. PLoS ONE 8(4), e62282 (2013).
  • PATH. Technology Solutions for Global Health: Balloon Tamponade 2013 Seattle, WA 98109, USA (2012).
  • Majumdar A, Saleh S, Davis M, Hassan I, Thompson PJ. Use of balloon catheter tamponade for massive postpartum haemorrhage. J. Obstet. Gynaecol. 30(6), 586–593 (2010).
  • Hezelgrave N, Unwin C, Baker E, Edmunds S, Shennan A. Low-cost automated BP monitors for the detection of pre-eclampsia in rural Tanzanian health clinics: 3 year follow up. (2012).
  • FIGO Safe Motherhood and Newborn Health Committee. Human resources for health in the low-resource world: Collaborative practice and task shifting in maternal and neonatal care”. Int. J. Gynecol. Obstet. 105(1), 74–76(2009).
  • World Health Organization. Optimizing health worker roles to improve access to key maternal and newborn health interventions through task shifting. (2012).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.